These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 26903553)
1. Growth patterns of patients with Noonan syndrome: correlation with age and genotype. Cessans C; Ehlinger V; Arnaud C; Yart A; Capri Y; Barat P; Cammas B; Lacombe D; Coutant R; David A; Baron S; Weill J; Leheup B; Nicolino M; Salles JP; Verloes A; Tauber M; Cavé H; Edouard T Eur J Endocrinol; 2016 May; 174(5):641-50. PubMed ID: 26903553 [TBL] [Abstract][Full Text] [Related]
2. PTPN11, SOS1, KRAS, and RAF1 gene analysis, and genotype-phenotype correlation in Korean patients with Noonan syndrome. Ko JM; Kim JM; Kim GH; Yoo HW J Hum Genet; 2008; 53(11-12):999-1006. PubMed ID: 19020799 [TBL] [Abstract][Full Text] [Related]
3. Noonan syndrome: relationships between genotype, growth, and growth factors. Limal JM; Parfait B; Cabrol S; Bonnet D; Leheup B; Lyonnet S; Vidaud M; Le Bouc Y J Clin Endocrinol Metab; 2006 Jan; 91(1):300-6. PubMed ID: 16263833 [TBL] [Abstract][Full Text] [Related]
4. Growth standards of patients with Noonan and Noonan-like syndromes with mutations in the RAS/MAPK pathway. Malaquias AC; Brasil AS; Pereira AC; Arnhold IJ; Mendonca BB; Bertola DR; Jorge AA Am J Med Genet A; 2012 Nov; 158A(11):2700-6. PubMed ID: 22887833 [TBL] [Abstract][Full Text] [Related]
5. PTPN11 (protein tyrosine phosphatase, nonreceptor type 11) mutations and response to growth hormone therapy in children with Noonan syndrome. Ferreira LV; Souza SA; Arnhold IJ; Mendonca BB; Jorge AA J Clin Endocrinol Metab; 2005 Sep; 90(9):5156-60. PubMed ID: 15956085 [TBL] [Abstract][Full Text] [Related]
6. PTPN11 and KRAS gene analysis in patients with Noonan and Noonan-like syndromes. Brasil AS; Pereira AC; Wanderley LT; Kim CA; Malaquias AC; Jorge AA; Krieger JE; Bertola DR Genet Test Mol Biomarkers; 2010 Jun; 14(3):425-32. PubMed ID: 20578946 [TBL] [Abstract][Full Text] [Related]
7. Response to growth hormone in short children with Noonan syndrome: correlation to genotype. Binder G Horm Res; 2009 Dec; 72 Suppl 2():52-6. PubMed ID: 20029239 [TBL] [Abstract][Full Text] [Related]
8. Dermatological manifestations in Noonan syndrome: a prospective multicentric study of 129 patients positive for mutation. Bessis D; Miquel J; Bourrat E; Chiaverini C; Morice-Picard F; Abadie C; Manna F; Baumann C; Best M; Blanchet P; Bursztejn AC; Capri Y; Coubes C; Giuliano F; Guillaumont S; Hadj-Rabia S; Jacquemont ML; Jeandel C; Lacombe D; Mallet S; Mazereeuw-Hautier J; Molinari N; Pallure V; Pernet C; Philip N; Pinson L; Sarda P; Sigaudy S; Vial Y; Willems M; Geneviève D; Verloes A; Cavé H Br J Dermatol; 2019 Jun; 180(6):1438-1448. PubMed ID: 30417923 [TBL] [Abstract][Full Text] [Related]
9. [Phenotype variability in Noonan syndrome patients with and without PTPN11 mutation]. Ferreira LV; Souza SA; Montenegro LR; Arnhold IJ; Pasqualini T; Heinrich JJ; Keselman AC; Mendonça BB; Jorge AA Arq Bras Endocrinol Metabol; 2007 Apr; 51(3):450-6. PubMed ID: 17546245 [TBL] [Abstract][Full Text] [Related]
10. Spectrum of mutations in Noonan syndrome and their correlation with phenotypes. Lee BH; Kim JM; Jin HY; Kim GH; Choi JH; Yoo HW J Pediatr; 2011 Dec; 159(6):1029-35. PubMed ID: 21784453 [TBL] [Abstract][Full Text] [Related]
11. Congenital sensorineural hearing loss as the initial presentation of Gao X; Huang SS; Qiu SW; Su Y; Wang WQ; Xu HY; Xu JC; Kang DY; Dai P; Yuan YY J Med Genet; 2021 Jul; 58(7):465-474. PubMed ID: 32737134 [TBL] [Abstract][Full Text] [Related]
12. Response to growth hormone therapy in children with Noonan syndrome: correlation with or without PTPN11 gene mutation. Choi JH; Lee BH; Jung CW; Kim YM; Jin HY; Kim JM; Kim GH; Hwang JS; Yang SW; Lee J; Yoo HW Horm Res Paediatr; 2012; 77(6):388-93. PubMed ID: 22777296 [TBL] [Abstract][Full Text] [Related]
13. Impact of Growth Hormone Therapy on Adult Height in Patients with PTPN11 Mutations Related to Noonan Syndrome. Malaquias AC; Noronha RM; Souza TTO; Homma TK; Funari MFA; Yamamoto GL; Silva FV; Moraes MB; Honjo RS; Kim CA; Nesi-França S; Carvalho JAR; Quedas EPS; Bertola DR; Jorge AAL Horm Res Paediatr; 2019; 91(4):252-261. PubMed ID: 31132774 [TBL] [Abstract][Full Text] [Related]
15. Genotype-phenotype correlation analysis in Japanese patients with Noonan syndrome. Shoji Y; Ida S; Niihori T; Aoki Y; Okamoto N; Etani Y; Kawai M Endocr J; 2019 Nov; 66(11):983-994. PubMed ID: 31292302 [TBL] [Abstract][Full Text] [Related]
16. Abnormal growth in noonan syndrome: genetic and endocrine features and optimal treatment. Padidela R; Camacho-Hübner C; Attie KM; Savage MO Horm Res; 2008; 70(3):129-36. PubMed ID: 18663312 [TBL] [Abstract][Full Text] [Related]
17. Analysis of the PTPN11 gene in idiopathic short stature children and Noonan syndrome patients. Ferreira LV; Souza SC; Montenegro LR; Malaquias AC; Arnhold IJ; Mendonca BB; Jorge AA Clin Endocrinol (Oxf); 2008 Sep; 69(3):426-31. PubMed ID: 18331608 [TBL] [Abstract][Full Text] [Related]
18. Abnormal growth in noonan syndrome: the challenge of optimal therapy. Savage MO; Padidela R; Kirk JM; Malaquias AC; Jorge AA Pediatr Endocrinol Rev; 2009 Jun; 6 Suppl 4():523-8. PubMed ID: 19550387 [TBL] [Abstract][Full Text] [Related]
19. Long-term GH treatment improves adult height in children with Noonan syndrome with and without mutations in protein tyrosine phosphatase, non-receptor-type 11. Noordam C; Peer PG; Francois I; De Schepper J; van den Burgt I; Otten BJ Eur J Endocrinol; 2008 Sep; 159(3):203-8. PubMed ID: 18562489 [TBL] [Abstract][Full Text] [Related]
20. Two cases of Noonan syndrome with severe respiratory and gastroenteral involvement and the SOS1 mutation F623I. Fabretto A; Kutsche K; Harmsen MB; Demarini S; Gasparini P; Fertz MC; Zenker M Eur J Med Genet; 2010; 53(5):322-4. PubMed ID: 20673819 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]